Kathryn Walsh, PhD
Predoctoral Trainee (previously held)
Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences
Pharmacology, Physiology & Biophysics

Websites
favorite icon LinkedIn



I recently received my PhD from Chobanian and Avedisian School of Medicine in the Dept of Pharmacology and Experimental Therapeutics where I studied the interaction of the sympathetic nervous system and an increase in dietary salt intake on renal sodium transporters in hypertension. My research resulted in 5 invited oral presentations at both the Experimental Biology and the American Heart Association: HBPR Conferences and a first-author publication.
More recently, I have been working as a Scientist in the Translational Sciences group at Intellia Therapeutics where we are working on developing curative genome editing treatments by harnessing the power of the CRISPR/Cas9 system in a lipid nanoparticle. I have been responsible for performing in vivo studies aimed at supporting studies in NHP and exploring the mechanism of our therapeutic in the liver.

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Gillmore JD, Gane E, Taubel J, Kao J, Fontana M, Maitland ML, Seitzer J, O'Connell D, Walsh KR, Wood K, Phillips J, Xu Y, Amaral A, Boyd AP, Cehelsky JE, McKee MD, Schiermeier A, Harari O, Murphy A, Kyratsous CA, Zambrowicz B, Soltys R, Gutstein DE, Leonard J, Sepp-Lorenzino L, Lebwohl D. CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis. N Engl J Med. 2021 08 05; 385(6):493-502. PMID: 34215024
     
  2. Puleo F, Kim K, Frame AA, Walsh KR, Ferdaus MZ, Moreira JD, Comsti E, Faudoa E, Nist KM, Abkin E, Wainford RD. Sympathetic Regulation of the NCC (Sodium Chloride Cotransporter) in Dahl Salt-Sensitive Hypertension. Hypertension. 2020 11; 76(5):1461-1469.View Related Profiles. PMID: 32981364; PMCID: PMC7727920; DOI: 10.1161/HYPERTENSIONAHA.120.15928;
     
  3. Frame AA, Puleo F, Kim K, Walsh KR, Faudoa E, Hoover RS, Wainford RD. Sympathetic regulation of NCC in norepinephrine-evoked salt-sensitive hypertension in Sprague-Dawley rats. Am J Physiol Renal Physiol. 2019 12 01; 317(6):F1623-F1636.View Related Profiles. PMID: 31608673; PMCID: PMC6960786; DOI: 10.1152/ajprenal.00264.2019;
     
  4. Walsh KR, Kuwabara JT, Shim JW, Wainford RD. Norepinephrine-evoked salt-sensitive hypertension requires impaired renal sodium chloride cotransporter activity in Sprague-Dawley rats. Am J Physiol Regul Integr Comp Physiol. 2016 Jan 15; 310(2):R115-24.View Related Profiles. PMID: 26608659; PMCID: PMC4796647; DOI: 10.1152/ajpregu.00514.2014;
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 4 publications over 4 distinct years, with a maximum of 1 publications in 2015 and 2019 and 2020 and 2021

YearPublications
20151
20191
20201
20211


Corner Office: Boston Medical Center CEO Kate Walsh takes a page out of Maya Angelou's book

Becker's Hospital Review 3/30/2022

Medical community rallies behind Boston doctors targeted by neo-Nazis

WGBH 2/8/2022

Boston Medical Center Health System Announces Health Equity Accelerator

Healthcare Innovation 11/17/2021

Boston Medical Center initiative aims to spot, tackle racial equity gaps

Becker's Hospital Review 11/16/2021
Contact for Mentoring:

Walsh's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (43) concept(s)
_
Media Mentions
_
Co-Authors
See all (4) people
_
Similar People
See all (60) people
_
Same Department
Search Department